Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases
Clinical trial NCT05435638 · COMPLETED
Trial details
- NCT number
- NCT05435638
- Sponsor
- Orvida Pharma (formerly Kamari Pharma)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-17
- Primary completion
- 2024-09-05
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.